JP2023514594A5 - - Google Patents
Info
- Publication number
- JP2023514594A5 JP2023514594A5 JP2022549303A JP2022549303A JP2023514594A5 JP 2023514594 A5 JP2023514594 A5 JP 2023514594A5 JP 2022549303 A JP2022549303 A JP 2022549303A JP 2022549303 A JP2022549303 A JP 2022549303A JP 2023514594 A5 JP2023514594 A5 JP 2023514594A5
- Authority
- JP
- Japan
- Prior art keywords
- mirna
- composition according
- orf
- composition
- target sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979619P | 2020-02-21 | 2020-02-21 | |
| US62/979,619 | 2020-02-21 | ||
| US202063059458P | 2020-07-31 | 2020-07-31 | |
| US63/059,458 | 2020-07-31 | ||
| PCT/US2021/019028 WO2021168405A1 (en) | 2020-02-21 | 2021-02-22 | Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514594A JP2023514594A (ja) | 2023-04-06 |
| JP2023514594A5 true JP2023514594A5 (https=) | 2024-03-01 |
| JP7539723B2 JP7539723B2 (ja) | 2024-08-26 |
Family
ID=77391786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549303A Active JP7539723B2 (ja) | 2020-02-21 | 2021-02-22 | コード化リボ核酸の器官保護発現及び調節のための組成物並びに方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11596685B2 (https=) |
| EP (1) | EP4106770A4 (https=) |
| JP (1) | JP7539723B2 (https=) |
| KR (2) | KR102838785B1 (https=) |
| CN (1) | CN115297868B (https=) |
| AU (2) | AU2021224990B2 (https=) |
| CA (1) | CA3168048A1 (https=) |
| IL (1) | IL295724A (https=) |
| MX (1) | MX2022010084A (https=) |
| WO (1) | WO2021168405A1 (https=) |
| ZA (1) | ZA202208795B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201714430D0 (en) * | 2017-09-07 | 2017-10-25 | Micol Romain | Compositions and processes for targeted delivery and expression and modulation of therapeutic components in tissue |
| EP4065600A1 (en) | 2019-11-25 | 2022-10-05 | Cornell University | Apoe gene therapy |
| CN113583977B (zh) * | 2020-04-30 | 2025-06-06 | 杭州康万达医药科技有限公司 | 可受微小rna调控的分离的重组溶瘤痘病毒及其应用 |
| MX2023001187A (es) * | 2020-07-31 | 2023-04-04 | Combined Therapeutics Inc | Composiciones y métodos para una vacunación mejorada. |
| CN116445492A (zh) * | 2022-01-10 | 2023-07-18 | 北京锦篮基因科技有限公司 | 用于x染色体连锁肾上腺脑白质营养不良的基因治疗药物和方法 |
| CN114874999B (zh) * | 2022-04-22 | 2023-04-21 | 中国医学科学院病原生物学研究所 | 一种基于痘苗病毒载体的新型冠状病毒病毒样颗粒疫苗 |
| CN116004628B (zh) * | 2023-01-03 | 2024-07-19 | 苏州大学 | 一种预防或治疗慢性疼痛的miRNA靶点及其应用 |
| CN117530932B (zh) * | 2024-01-08 | 2024-04-26 | 中国药科大学 | 一种抑制肿瘤生长及肺转移的人工外泌体及其应用 |
| WO2025251079A1 (en) * | 2024-05-31 | 2025-12-04 | University Of Massachusetts | Rna compositions and methods of use thereof in the treatment of cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7683036B2 (en) | 2003-07-31 | 2010-03-23 | Regulus Therapeutics Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| WO2009012263A2 (en) | 2007-07-18 | 2009-01-22 | The Trustees Of Columbia University In The City Of New York | Tissue-specific micrornas and compositions and uses thereof |
| US7993831B2 (en) * | 2007-09-14 | 2011-08-09 | Asuragen, Inc. | Methods of normalization in microRNA detection assays |
| WO2010126766A1 (en) * | 2009-04-30 | 2010-11-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inducible interleukin-12 |
| CA3018046A1 (en) | 2011-12-16 | 2013-06-20 | Moderna Therapeutics, Inc. | Modified nucleoside, nucleotide, and nucleic acid compositions |
| CN108474003A (zh) | 2015-11-20 | 2018-08-31 | 俄勒冈健康与科学大学 | 包含微小rna识别元件的cmv载体 |
| SI3458083T1 (sl) * | 2016-05-18 | 2023-03-31 | Modernatx, Inc. | Polinukleotidi, ki kodirajo interlevkin-12 (IL12) in njihova uporaba |
| CN110402145A (zh) * | 2016-10-26 | 2019-11-01 | 莫得纳特斯公司 | 用于增强免疫应答的信使核糖核酸及其使用方法 |
| WO2018115527A2 (en) * | 2016-12-23 | 2018-06-28 | Curevac Ag | Mers coronavirus vaccine |
| GB201714430D0 (en) | 2017-09-07 | 2017-10-25 | Micol Romain | Compositions and processes for targeted delivery and expression and modulation of therapeutic components in tissue |
| EP4008333A1 (en) * | 2018-02-19 | 2022-06-08 | Combined Therapeutics, Inc. | Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids |
| EP3986447A4 (en) * | 2019-06-18 | 2023-08-16 | Citranvi Biosciences, LLC | RATIONALLY MANIPULATED CARRIER PROTEINS FOR VACCINES |
| GB2594683A (en) * | 2020-02-17 | 2021-11-10 | Vaxbio Ltd | Vaccine |
-
2021
- 2021-02-22 JP JP2022549303A patent/JP7539723B2/ja active Active
- 2021-02-22 WO PCT/US2021/019028 patent/WO2021168405A1/en not_active Ceased
- 2021-02-22 AU AU2021224990A patent/AU2021224990B2/en active Active
- 2021-02-22 MX MX2022010084A patent/MX2022010084A/es unknown
- 2021-02-22 EP EP21757897.0A patent/EP4106770A4/en active Pending
- 2021-02-22 KR KR1020227031791A patent/KR102838785B1/ko active Active
- 2021-02-22 KR KR1020257024617A patent/KR20250114450A/ko active Pending
- 2021-02-22 IL IL295724A patent/IL295724A/en unknown
- 2021-02-22 CA CA3168048A patent/CA3168048A1/en active Pending
- 2021-02-22 CN CN202180016068.7A patent/CN115297868B/zh active Active
-
2022
- 2022-03-08 US US17/689,908 patent/US11596685B2/en active Active
- 2022-08-05 ZA ZA2022/08795A patent/ZA202208795B/en unknown
-
2023
- 2023-02-10 US US18/108,248 patent/US11931409B2/en active Active
-
2024
- 2024-02-08 US US18/436,426 patent/US12220456B2/en active Active
-
2025
- 2025-02-07 US US19/048,760 patent/US20250170233A1/en active Pending
- 2025-11-21 AU AU2025271119A patent/AU2025271119A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023514594A5 (https=) | ||
| Salleh et al. | Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2 | |
| JP2025063030A5 (https=) | ||
| Rösler et al. | Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia—a new therapeutic strategy? | |
| JP2022547313A5 (https=) | ||
| WO2021233213A1 (zh) | mRNA或mRNA组合物及其制备方法和应用 | |
| Park et al. | Induction of protective immune responses at respiratory mucosal sites | |
| WO2021155760A1 (zh) | 用于2019-nCoV型冠状病毒mRNA疫苗、制备方法及其应用 | |
| Chai et al. | Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis | |
| JP2023527791A5 (https=) | ||
| WO2024041612A1 (zh) | 一种正痘病毒属mRNA疫苗及其制备方法和用途 | |
| EP1696954B1 (fr) | Composition vaccinale adjuvantée par une alkylphosphatidylcholine | |
| Maurya et al. | Novel stem cells and nucleic acid-based vaccine trials against viral outbreak: a systematic evaluation during COVID-2019 pandemic | |
| US20240327865A1 (en) | Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof | |
| CN116568309B (zh) | 一种用于预防或治疗慢性乙型肝炎的药物组合制剂及其用途以及组合制剂试剂盒 | |
| CN1044092C (zh) | 抗原－抗体－重组dna复合型疫苗 | |
| US8357363B2 (en) | Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom | |
| EP3708187A1 (en) | Single high dose of mva induces a protective immune response in neonates and infants | |
| JP5906019B2 (ja) | 免疫刺激ｇ９．１の抗結核ブースターワクチン創出への応用 | |
| CN121405821B (zh) | 一种融合蛋白及在制备治疗或预防乙肝病毒产品中的应用 | |
| JP2024525578A5 (https=) | ||
| WO2022000845A1 (zh) | 一种预防SARS-CoV-2的重组蛋白疫苗及其制备方法 | |
| TW202417037A (zh) | 四元免疫調節奈米粒子用於醫學應用及免疫療法之方法及組成物 | |
| JP5699093B2 (ja) | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 | |
| CN118593695B (zh) | 一种用于治疗HBV感染的siRNA和mRNA联合疫苗 |